Please login to the form below

Not currently logged in

Excellence in Building Corporate Reputation and Trust

Back to categories

Judging criteria:

Clarity of situation analysis and opportunity identification (10)

  • Demonstrate how you gained in-depth understanding of the value that might be created beyond the product in line with stakeholder needs

Clarity and appropriateness of SMART objectives (10)

  • Demonstrate how your objectives related to all stakeholders and reinforced each other

Quality of strategy development based on insights (15)

  • Demonstrate what specific insights led to your choice of the particular strategy
  • Evidence of resource allocation decisions designed to create value
  • Evidence of choices not to allocate resources

Quality of execution (15)

  • Evidence as to how methods and tactics were based on the strategy
  • Evidence as to how methods and tactics reinforced each other
  • Evidence of organisational changes made to support strategy execution
  • Evidence of working with other stakeholders to support strategy execution and identify new opportunities

Quality of measurement and learning (10)

  • Demonstrate how metrics have been applied to measure outcomes
  • Evidence of knowledge gained that will inform and shape future decision-making

Evidence of value creation (15)

  • Evidence of improved clinical outcomes
  • Evidence of improved industry reputation/clinical outcomes/health economic outcomes
  • Evidence of other improved outcomes

Evidence of improvement in reputation and trust (10)

This award recognises excellence in work, conducted by any organisation involved in any market, which shows a commitment to making a difference to communities/society, building trust in and enhancing the reputation of the pharmaceutical industry, whilst improving clinical outcomes and/or health economic value, whilst addressing stakeholder needs. These include, but are not restricted to:

  • The use of technology to make the use of a pharmaceutical therapy more clinically or economically effective, or both
  • The use of technology and services that improve the patient/clinical experience
  • Approaches to improving compliance or use of the product that lead to better clinical or health economic value, or both
  • Supporting healthcare systems in the delivery of service
  • The development and delivery of services delivered leading to a better experience for stakeholders/patients/customers.

Entries are invited from any individual, team, service or organisation that has improved reputation and trust within the pharmaceutical industry. Judges will be looking for evidence of impact, sustainability and innovation.

Work conducted in the two-year period from  July 2018 to June 2020 will be eligible.


Page & Page Logo

Back to categories